Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
CDKL5 Disorder
Zogenix, Inc.
P3
B
(60)
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
Epilepsy With Generalized Tonic-Clonic Seizures
Zogenix, Inc.
P3
B
(60)
Bicalutamide
Hypogonadism
SWOG Cancer Research Network
P3
B
(60)
Bleomycin
Embryonal Carcinoma
Children's Oncology Group
P3
B
(60)
Bleomycin
Germ Cell Tumor
Children's Oncology Group
P3
B
(60)
Bleomycin
Malignant Germ Cell Tumor
Children's Oncology Group
P3
B
(60)
Bleomycin
Ovarian Neoplasm
Beihua Kong
P3
B
(60)
Bleomycin
Choriocarcinoma Of Ovary
Children's Oncology Group
P3
B
(60)
Bleomycin
Choriocarcinoma Of Testis
Children's Oncology Group
P3
B
(60)
Bleomycin
Testicular Seminoma
Children's Oncology Group
P3
B
(60)
Bleomycin
Testicular Yolk Sac Tumor
Children's Oncology Group
P3
B
(60)
Bleomycin
Mixed Testicular Germ Cell Cancer
Children's Oncology Group
P3
B
(60)
Blinatumomab
Central Nervous System Leukemia
Children's Oncology Group
P3
B
(60)
Blinatumomab
Testicular Leukemia
Children's Oncology Group
P3
B
(60)
Bl-M07D1
HER2 Positive Breast Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P3
B
(60)
Bl-M14D1
Lung Carcinoma
SystImmune Inc.
P3
B
(60)
Bl-M14D1
Small Cell Carcinoma
SystImmune Inc.
P3
B
(60)
Boclatixafortide
Marginal Zone Lymphoma
Pentixapharm AG
P3
B
(60)
Bortezomib
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
B
(60)
Bortezomib
AL Amyloidosis
Alexion Pharmaceuticals, Inc.
P3
B
(60)
Bortezomib
T-Cell Childhood Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P3
B
(60)
Brentuximab Vedotin
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
B
(60)
Buserelin
Prostate Cancer
NRG Oncology
P3
B
(60)
Cabozantinib
Malignant Soft Tissue Neoplasm
National Cancer Institute (NCI)
P3
B
(60)
Calaspargase Pegol
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Children's Oncology Group
P3
B
(60)
Showing 2826 to 2850 of 5,098 assets
Previous
Page 114 of 204
Next